Tag archives: deal volume

Looking Beyond COVID-19: How Companies Can Prepare for the Post-Pandemic Economy

By nrfdigitalteam on April 14, 2020 Posted in M&A

As COVID-19 continues to sweep across the world, it is has undoubtedly taken the global financial markets by storm. Despite the unprecedented social and economic disruptions brought by the pandemic, Ernst & Young’s Capital Confidence Barometer Survey (the Survey) of more than 2,900 C-suite executives globally shows that more than half (56%) of them continue … Continue reading

Canadian M&A Q3 2019 Review: Canadian M&A activity remains strong despite a slight decline in transaction volume

By nrfdigitalteam on October 31, 2019 Posted in M&A

Crosbie & Company’s “Crosbie & Company Canadian Mergers & Acquisitions Report for Q3 2019” (the Report) reviews the minor slowdown in Canadian M&A activity in Q3 2019 following a record-breaking second quarter. While deal activity declined slightly in Q3 (776 announced transactions compared to 886 in Q2), the Canadian M&A market remained robust, posting its … Continue reading

Venture capital investments take off in the first quarter of 2019

By Troy Ungerman (Toronto) on June 6, 2019 Posted in Corporate finance, Finance

The Canadian Venture Capital & Private Equity Association (the CVCA) has recently provided insights into Canadian investment trends for the first quarter of 2019 (Q1 2019). The CVCA has indicated that Private Equity (PE) deals have slowed in Q1 compared to their Venture Capital (VC) counterparts. VC investments have almost doubled since Q1 2018, whereas PE investments have … Continue reading

Building the health systems of tomorrow: dealmaking and the future of the life sciences sector

By Troy Ungerman (Toronto) on April 23, 2019 Posted in M&A, Pharmaceuticals and life sciences

EY has recently published a year-in-review report for deal making in the global life sciences industry. The publication features some interesting statistics about deal activity in the past year, and makes predictions about which trends will carry forward into the 2019 and beyond. The total value of life sciences deals in 2018 was US $198 … Continue reading

Outlook for 2019: cross-border M&A and post-merger integration

By Troy Ungerman (Toronto) on April 3, 2019 Posted in M&A

Despite a general environment of uncertainty, 2018 was quite active in the cross-border M&A arena. However, observers expect a global drop for this year, especially for the mega-deals (i.e. transactions with deal values exceeding $10 billion) amid uncertainty over Brexit and the threat of globe trade wars. Accordingly, acquirers are increasingly focusing on domestic deals rather … Continue reading

Asset and wealth management M&A activities in 2018 and beyond

By Troy Ungerman (Toronto) on February 28, 2019 Posted in M&A

Merger and acquisition activities in 2018 in the asset and wealth management sector logged a total of 140 deals, up 5% from last year. According to an overview published by PwC, the total announced value of the M&A deals was US$14.9 billion, which represented a year-over-year increase up 72% – the highest percentage increase since … Continue reading

“Crazy Rich Asia” – record growth in the Asia-Pacific region

By nrfdigitalteam on February 7, 2019 Posted in M&A

The Asia-Pacific region experienced a strong year for mergers and acquisitions (“M&A”) in 2018 and the level of M&A activity in this region is expected to continue in 2019. It was anticipated that 2018 would be a busy year with regards to M&A for Asia-Pacific companies and these predictions proved to be true. In the … Continue reading

Looking back at M&A activity in 2018

By Olga Lenova (Toronto) on January 8, 2019 Posted in M&A

Looking back at global M&A activity during 2018, a report on global M&A by Mergermarket shows that while global M&A deal value rose over the last year, the number of deals fell for the first time since 2010. The value of deals rose to $3.53 trillion US dollars, an increase of 11.5% since 2018, making … Continue reading

Q3 review: global M&A volume dropping, despite record highs

By nrfdigitalteam on October 11, 2018 Posted in M&A

Thomson Reuters recently released a report on global mergers and acquisitions in the first nine months of 2018. According to the report, global M&A volume fell 32% in Q3 2018 compared to Q2 2018. The number of deals – 35,543 – in the first nine months of 2018 dropped 9% compared to the same period … Continue reading

Canadian venture capital investment continues to increase in H1 2018

By Troy Ungerman (Toronto) on September 6, 2018 Posted in Corporate finance, Technology and innovation

The Canadian Venture Capital & Private Equity Association recently published its 2018 first half (H1 2018) report on Canadian venture capital (VC) and Canadian private equity (PE) investment. While Canadian PE investment remains feeble, Canadian VC investment has continued to climb to incredible heights. A review of the increasing trends in Canadian VC investment, with respect … Continue reading

Grow on! Examining the forces behind increased M&A activity in Canada

By Troy Ungerman (Toronto) on September 5, 2018 Posted in Cannabis, M&A, Pharmaceuticals and life sciences

The Canadian market has seen a surge in M&A activity since 2017 and it looks as though 2018 will follow suit. According to a PwC Canada 2018 M&A mid-year review, in the first half of 2018 alone, Canada hit CAD$93 billion in M&A activity and outbound deals increased by 8% as compared to the first … Continue reading

Not all bad news amidst African M&A decrease

By Troy Ungerman (Toronto) on August 9, 2018 Posted in M&A

Recent reports have suggested a precipitous decline in mergers and acquisitions (M&A) in Africa. In the first half of 2018, total deal volumes and values of M&A transactions declined with a 44% decrease in deal volume and a 57% decrease in aggregate value, in comparison to figures in the preceding year. In fact, M&A transactions on the … Continue reading

A healthy dose of deal-making: M&A trends in the US and Canadian healthcare sector

By Troy Ungerman (Toronto) on May 3, 2018 Posted in M&A, Pharmaceuticals and life sciences

In the first quarter of 2018, M&A activity across the world hit a 17 year record high according to Mergermarket’s Q1 2018 Global M&A Report. This is an 18 percent increase in value compared to the first quarter of 2017. This increase was affected by the surge in deal-making seen at the end of 2017 … Continue reading

Are megadeals coming back?

By nrfdigitalteam on April 12, 2018 Posted in Antitrust, competition and regulatory, M&A

The year of 2017 witnessed a worldwide slowdown in the number of megadeals[1]. According to a recent Mergermarket Report (the Report), the global total for the number of deals worth US$4 billion or more decreased from a peak of 158 in 2015 and 133 in 2016 to 129 in 2017. In Canada, the number of … Continue reading

The tech takeover: disruptive technology as a driver of M&A

By nrfdigitalteam on April 11, 2018 Posted in M&A, Technology and innovation

A relentless parade of new technologies is unfolding on many fronts – one of which includes the M&A scene. While not every emerging technology will alter a business’ landscape, certain technologies have the potential to disrupt the status quo, alter the way companies operate and rearrange value pools. These “disruptive technologies” can quickly displace established … Continue reading

A global overview of M&A activity: H1 2016

By Troy Ungerman (Toronto) on August 25, 2016 Posted in M&A

MergerMarket Group recently published its July edition of Monthly M&A Insider which reported on mergers and acquisitions activity around the world during the first half of 2016, which was marked by a departure from last year’s record highs. Global M&A Global deal values fell by 26.8% to US$1.3tn across 7,794 transactions from H1 2015’s US$1.8tn … Continue reading